• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (2)
    • Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.
    • The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    • See All 2 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.

The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience. 2007 Aug 10; 148(1):34-43.

View in: PubMed

subject areas
  • Aging
  • Animals
  • Animals, Genetically Modified
  • Ataxin-3
  • Disease Models, Animal
  • Female
  • Hypothalamus
  • Immunohistochemistry
  • Intracellular Signaling Peptides and Proteins
  • Male
  • Narcolepsy
  • Nerve Degeneration
  • Nerve Tissue Proteins
  • Neurons
  • Neuropeptides
  • Nuclear Proteins
  • Orexins
  • Peptides
  • Promoter Regions, Genetic
  • Rats
  • Rats, Sprague-Dawley
  • Repressor Proteins
  • Sleep, REM
  • Up-Regulation
  • Wakefulness

authors with profiles
  • Carlos A. Blanco-Centurion
  • Priyattam J. Shiromani